Anyone in clinical trial with pasritamig, (T-cell engaging antibody)?
anyone have experience with this clinical trial
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
anyone have experience with this clinical trial
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
Johnson& Johnson describes pasritamig as a first-in-class bispecific T-cell-engaging antibody that shows potential in treating metastatic castration-resistant prostate cancer (mCRPC).
@alperk, which clinical trial involving pasritamig are you referring to? There are several listed here: https://www.cancer.gov/research/participate/clinical-trials/intervention/pasritamig
The one being done at Florida Cancer Specialists in Sarasota monitored by their Fort Myers office